Head & neck · 2025
Segmental Tracheal Resection for Thyroid Cancer: Perioperative Morbidity, Locoregional Control, and Survival.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Maniakas Anastasios, Wilde David C, Fournier Isabelle, Hyde Emily K, Xu Li, Wang Jennifer R, Gross Neil D, Sturgis Erich M, Banuchi Victoria, Busaidy Naifa L, Cabanillas Maria E, Iyer Priyanka, Dadu Ramona, Waguespack Steven G, Hu Mimi I, Gunn G Brandon, Kwon Michael, Ahmed Salmaan, Williams Michelle D, Zafereo Mark E
Аннотация
BACKGROUND: Segmental tracheal resection is rarely needed for advanced thyroid cancer but is among the most complex, high-risk thyroid surgeries.
METHODS: Retrospective study of patients undergoing segmental tracheal resection for thyroid cancer at MD Anderson Cancer Center (2005-2024).
RESULTS: We identified 120 patients with a median follow-up of 4.6 years (range 0.02-16.38). Papillary thyroid cancer was most common (68%). The median number of tracheal rings resected was 4 (range 1-9). Seventeen (14%) patients had a new tracheostomy placed at the time of surgery, with 11 (9%) remaining trach-dependent at last follow-up. Twenty-six (22%) patients had a return to the operating room within 30 days, while 3 (3%) patients suffered perioperative mortality. The more common postoperative complications included tracheostomy tube placement (10%), hematoma (7%), and anastomotic air leak (6%). Median hospitalization was 6 days (range 2-67). Locoregional control (LRC) and overall survival (OS) were 79% and 77% at 5 years, respectively.
CONCLUSIONS: Segmental tracheal resection for advanced thyroid cancer is technically complex and high-risk, but most patients stay recurrence-free 5 years post-surgery.
METHODS: Retrospective study of patients undergoing segmental tracheal resection for thyroid cancer at MD Anderson Cancer Center (2005-2024).
RESULTS: We identified 120 patients with a median follow-up of 4.6 years (range 0.02-16.38). Papillary thyroid cancer was most common (68%). The median number of tracheal rings resected was 4 (range 1-9). Seventeen (14%) patients had a new tracheostomy placed at the time of surgery, with 11 (9%) remaining trach-dependent at last follow-up. Twenty-six (22%) patients had a return to the operating room within 30 days, while 3 (3%) patients suffered perioperative mortality. The more common postoperative complications included tracheostomy tube placement (10%), hematoma (7%), and anastomotic air leak (6%). Median hospitalization was 6 days (range 2-67). Locoregional control (LRC) and overall survival (OS) were 79% and 77% at 5 years, respectively.
CONCLUSIONS: Segmental tracheal resection for advanced thyroid cancer is technically complex and high-risk, but most patients stay recurrence-free 5 years post-surgery.